DexCom, Inc.
NASDAQ:DXCMMedical - Devices
+$0.90 today
- Market cap
- $30.78B
- Beta
- 1.44
- P/E (TTM)
- 29.9
- EPS (TTM)
- $2.42
Volume 4.25M
Average 5.43M
DXCM Other Non-current Assets
Long-term assets not reported separately.
DexCom, Inc.NASDAQ: DXCM
Other Non-current Assets · Q2 FY2026 · quarter ended Jun 2026
Other non-current assets rises 7.5% from a year ago
Other non-current assets stood at $64.2M at the end of Q2 FY2026, up 7.5% from a year earlier and down 3.3% from the prior quarter. Over 3 fiscal years it compounded at +29.3% a year.
Context
- Other non-current assets amounted to 1.0% of total assets at the end of Q2 FY2026, up 0.2 pp from a year earlier.
- Other non-current assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +7.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 60.7M USD
- Year-over-year change
- +13.0%
- 4-year CAGR
- +55.1%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 60.7M | +13.0% |
| FY2024 | 2024-12-31 | 53.7M | +47.1% |
| FY2023 | 2023-12-31 | 36.5M | +29.9% |
| FY2022 | 2022-12-31 | 28.1M | +167.6% |
| FY2021 | 2021-12-31 | 10.5M | — |
Other Non-current Assets vs competitors
How DXCM compares with its peers on the latest reported figures
- DXCM's Jun 2026 other non-current assets of $64.2M is the 3rd highest of the 7 companies compared; the peer median is $15.77M.
- Its year-over-year change of +7.5% is the 3rd highest of 6, against a peer median of -14.8%.
- Other non-current assets amounts to 1.0% of total assets for DXCM, versus a peer median of 1.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $271.6M | -14.8% | -3.2% | 8.6% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $135M | — | — | 2.9% |
| Jun 2026 | $64.2M | +7.5% | +29.3% | 1.0% | |
| Mar 2026 | $30.82M | +312.9% | +6.4% | 2.7% | |
| Mar 2026 | $720K | +117.5% | +68.7% | 0.7% | |
| Mar 2026 | $376K | -91.4% | +6.3% | 0.4% | |
| Mar 2026 | $181K | -26.4% | -2.3% | 0.1% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding DXCM) | $15.77M | -14.8% | +6.3% | 1.7% | |
Competitors are the stored peer set for DXCM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.05B | 642.3M | 566.3M | 606.1M | 917.7M |
| Short-term Investments | 1.68B | 1.81B | 2.16B | 1.97B | 1.08B |
| Net Receivables | 516.6M | 752.2M | 987.5M | 1.03B | 1.29B |
| Inventory | 357.3M | 306.7M | 559.6M | 542.6M | 629.1M |
| Other Current Assets | 27.4M | 37M | 64.5M | 58.3M | 49.2M |
| Total Current Assets | 3.68B | 3.67B | 4.43B | 4.3B | 4.03B |
| Property, Plant & Equipment (Net) | 889.9M | 1.14B | 1.18B | 1.4B | 1.64B |
| Goodwill | 26.5M | 25.7M | 25.2M | 22.8M | 24.2M |
| Intangible Assets | 31.5M | 173.3M | 134.5M | 103.4M | 70.8M |
| Long-term Investments | 0 | 19M | 38.5M | 119.3M | 218M |
| Tax Assets | 290.5M | 341.2M | 419.4M | 481.2M | 295.6M |
| Other Non-current Assets | 10.5M | 28.1M | 36.5M | 53.7M | 60.7M |
| Total Non-current Assets | 1.25B | 1.72B | 1.84B | 2.18B | 2.31B |
| Total Assets | 4.93B | 5.39B | 6.26B | 6.48B | 6.34B |
| Account Payables | 189.4M | 237.9M | 276.4M | 345.3M | 344.3M |
| Short-term Debt | 0 | 772.6M | 0 | 1.2B | 0 |
| Tax Payables | 40.7M | 44.8M | 50.1M | 42.3M | 0 |
| Deferred Revenue | 2.1M | 10.1M | 18.4M | 8M | 7.7M |
| Other Current Liabilities | 48.4M | 47.7M | 46.4M | 56.1M | 54.6M |
| Total Current Liabilities | 720.8M | 1.84B | 1.56B | 2.93B | 2.14B |
| Long-term Debt | 1.98B | 1.2B | 2.43B | 1.24B | 1.24B |
| Deferred Tax Liabilities | 5.9M | 4.9M | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 16.1M | 19M | 7.4M | 9.5M | 0 |
| Other Non-current Liabilities | 11M | 44.8M | 59.6M | 79.9M | 83.3M |
| Total Non-current Liabilities | 2.17B | 1.42B | 2.64B | 1.45B | 1.45B |
| Total Liabilities | 2.89B | 3.26B | 4.2B | 4.38B | 3.59B |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 138.7M | 479.9M | 1.02B | 1.6B | 2.43B |
| Accumulated OCI | 500K | (11.6M) | (16.7M) | (8M) | 115M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.04B | 2.13B | 2.07B | 2.1B | 2.75B |
| Total Debt | 2.16B | 2.15B | 2.59B | 2.59B | 1.39B |
| Net Debt | 1.11B | 1.5B | 2.03B | 1.98B | 472M |
DexCom, Inc.
NASDAQ:DXCM
Intrinsic Alpha fair value
Locked
Current Price
$82.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.